Epigral Limited

Epigral Limited (EPIGRAL) is a micro-cap Chemicals company valued at ₹4,292 crore operating in Specialty Chemicals on the NSE and BSE.

Recent price move

Epigral Limited last traded at ₹994, up 2.01% on the day.

Recent developments

On 2026-06-01, the company announced a dividend of ₹5.00 per share, effective from that date. Promoter holding remained at 68.83% as of 2026-06-30, with foreign institutional holding decreasing by 0.51 percentage points and domestic institutional holding increasing by 0.66 percentage points in the quarter.

Financial performance

The company's annual revenue fell 0.9% year-over-year, while net profit declined 7.0%. In the latest quarter, revenue rose 16.2% compared to the same quarter a year earlier, but net profit dropped 37.7%, indicating a widening gap between revenue growth and profitability.

Valuation multiples

The stock trades at 12.9 times earnings, 1.91 times book value. It yields 0.5%.

Things to watch

Net profit margin narrowed by 0.9 percentage points to 13.1%, and the latest quarter's net profit fell 37.7% compared to the same quarter a year earlier. The stock is 44.3% below its 52-week high, and profit growth has slowed significantly in the past year.

Where it stands

The company's revenue growth has slowed in recent years, with annual revenue declining 0.9% and profit falling 7.0% year-over-year. The latest quarter saw revenue rise 16.2% but net profit drop 37.7%, highlighting challenges in maintaining profitability. Promoter holding remains at 68.83%, while foreign institutional holding decreased slightly.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.